CSN Login
Members Online: 4

You are here

FDA has approved Cyramza (ramucirumab) treatment of advanced or metastatic gastric cancer or gastro-esophageal junction

dfd24
Posts: 91
Joined: Mar 2011

The FDA has approved Cyramza (ramucirumab) 10mg/mL injection for the treatment of patients with advanced or metastatic gastric cancer or gastro-esophageal junction (GEJ) adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. 

alexandra phan md says :"Ramucirumab is a fully humanized monoclonal antibody against the vascular endothelial growth factor receptor 2 (VEGFR2). This is a biological agent that has been tested in several cancers including stomach and lung cancers. On Monday, the FDA approved this agent for the treatment of patients with advanced gastric or gastro-esophageal junction (GEJ) cancers. ......"

link:http://www.chemotherapyadvisor.com/fda-approval-of-cyramza-offers-hope-for-gastric-cancer-patients/article/343942/#expertopinion

 

danièle

Grateful4Forum
Posts: 15
Joined: Apr 2014

Hi Danièle,

Thanks for sharing these important updates!

Take care

NLMCEM
Posts: 53
Joined: Aug 2010

This is very hopeful for those who may be healthy enough to go this route. Unfortunately our doctor and team a long with the warnings for this is not 1 my husband will be able to try. Hoping to hear how it helps others though.